OptiNose (NASDAQ: OPTN) reported Q4 EPS of ($0.03), in-line with the analyst estimate of ($0.03). Revenue for the quarter came in at $22.42 million versus the consensus estimate of $28.21 million.

For earnings history and earnings-related data on OptiNose (OPTN) click here.